Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?50.96
 
WKN: A14YW4 / Symbol: KARO / Name: Karo Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Karo Pharma AB Stock

Karo Pharma AB is currently one of the favorites of our community with 7 Buy predictions and no Sell predictions.
Based on the current price of 5.44 € the target price of 50 € shows a potential of 819.12% for Karo Pharma AB which would more than double the current price.

Pros and Cons of Karo Pharma AB in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Karo Pharma AB vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Karo Pharma AB - - - - - - -
Medivir AB 2860.000% -35.371% -62.051% -92.600% -93.180% -98.265% -98.676%
Active Biotech AB 9.680% -30.612% -55.263% 209.091% -76.552% -96.000% -97.518%
Actinium Pharmaceuticals Inc. -1.880% 0.000% 11.883% -4.599% 6.342% -87.772% -86.400%

Comments

Karooooo (NASDAQ:KARO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for KARO provided by MarketBeat
Show more

Karooooo (NASDAQ:KARO) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "strong-buy" rating.
Ratings data for KARO provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 50.958
Change
Ends at 24.07.26

Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James Financial, Inc.. They now have a $60.00 price target on the stock, up previously from $58.00.
Ratings data for KARO provided by MarketBeat
Show more